Effects of sitagliptin beyond glycemic control: focus on quality of life

BACKGROUND: Recently, incretin hormones, including glucagon-like peptide-1 (GLP-1) analogue and dipeptidyl peptidase-4 (DPP-4) inhibitor, have been found to regulate glucose metabolism. The aim of this study was to elucidate the efficacy and safety of the clinical usage of DPP-4 inhibitors in Japan....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sakamoto, Yoshiko, Oyama, Jun-ichi, Ikeda, Hideo, Kuroki, Shigetaka, Gondo, Shigeki, Iwamoto, Taketo, Uchida, Yasufumi, Kodama, Kazuhisa, Hiwatashi, Atsushi, Shimomura, Mitsuhiro, Taguchi, Isao, Inoue, Teruo, Node, Koichi
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3606450/
https://ncbi.nlm.nih.gov/pubmed/23432786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-12-35
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires